http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201023866-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_faad4d14d50ca111925381f14c69abdf
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
filingDate 2008-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22b358ab09aec8d14d21cb469ae9d4ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afea7f6eb98c687bccdfe6d9bbc0f0b3
publicationDate 2010-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TW-201023866-A
titleOfInvention Method for inhibiting production of very late antigen-4 in a cell
abstract A method for inhibiting production of VLA-4 in a cell comprises the step of: applying eriodictyol to a cell. Consequently, an anti-inflammation effect is provided to avoid allergy, asthma, rheumatoid arthritis and cardiovascular diseases.
priorityDate 2008-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100032965
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25361
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID107393082
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4929
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322230
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7412
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID22329
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID440735
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496535
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530446
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579222

Total number of triples: 24.